Basics Immunocore Holdings IPO Date: February 5, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.96B Activated in VL: True Average Daily Range Avg Daily Range: $1.03 | 2.47% Avg Daily Range (30 D): $0.81 | 2.29% Avg Daily Range (90 D): $0.64 | 1.85% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,778 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $1.35M Avg Inst. Trade (90 D): $1.56M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $1.65M Avg Closing Volume: 35.62K     News Nov 7, 2025 @ 1:00 PM Immunocore presents Phase 1 data for hepatitis B c... Source: Immunocore Holdings Plc Oct 30, 2025 @ 3:15 PM Growth Picks: 3 Low-Cost Stocks That Could Double ... Source: Chris Markoch Aug 7, 2025 @ 3:54 PM Immunocore (IMCR) Q2 Revenue Jumps 30% Source: Jesterai Mar 10, 2025 @ 7:00 PM Immunocore presents initial multiple ascending dos... Source: N/A Mar 6, 2025 @ 6:00 PM TCR Therapy Clinical Trial Pipeline Accelerates as... Source: Delveinsight Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.58 $ $-.2 Diluted EPS $-.58 $ $-.2 Revenue $ 379.59M $ 103.69M $ 97.96M Gross Profit $ 376.88M $ 103.18M $ 96.92M Net Income / Loss $ -29.23M $ -.18M $ -10.3M Operating Income / Loss $ -45.11M $ -7.17M $ -14.88M Cost of Revenue $ 2.71M $ .51M $ 1.04M Net Cash Flow $ -39.35M $ 10.48M $ 11.09M PE Ratio